Sustainability Report 2013 Lek d.d.

27 Environment 35 EMAS Core Indicator 36 GRI G4-DMA Graph 2: Efficacy of the use of various materials per unit of product 35 – by site and total Lendava Lek d.d. Ljubljana Menge‰ Prevalje Efficacy of the use of raw materials per unit of product Efficacy of the use of raw materials - total 40 10 50 12 2009 2009 30 8 20 6 10 2 4 0 0 t/t t/t year year 2010 2010 2011 2011 2012 2012 2013 2013 2.2.4 Sustainable packaging approach 36 The two production sites manufacturing finished dos- age forms are the major consumers of packaging material: Ljubljana with 62% and Prevalje with 33%. At the Menge‰ and Lendava sites packaging consumption accounts for less than 5% of the total packaging consumption of Lek d.d. In accordance with the Novartis’ policy of sustainable use of the packaging and binding waste management hierarchy, we defined the basic principles of packaging design and production: • Selection of materials: - Using materials of lower environmental impact (naturally light materials, recycling-based materials, recyclable materials from renewable sources that contain no toxic ingredients), - Using a small number of various materials that have to be recyclable. • Packaging shaping and size: - Reducing the total weight of materials (thinner and lighter materials), - Reducing the volume (reduced environmental impact of transport), - Reducing the number of packaging types (including inte- gration of primary and secondary packaging into one, uniform packaging to meet various customer needs). • Ordering packaging materials: - Cooperation with environmentally and socially res- ponsible suppliers, - Using exclusively environmentally certified / recom- mended materials (e.g. non-chlorine bleached paper, certified cotton...), - Cooperation with local/regional packaging suppliers (lower environmental impact of transport). Results of improvements in 2013: • By optimizing packaging of the product containing flu- vastatin we reduced the blister surface by 25%, the box volume by 20% and the packaging weight by 5%. • In one product, blisters were replaced by plastic bottles which reduced the blister volume by 50%. The number of packs per pallet was increased by the same propor- tion, resulting in environmentally more optimal use of transport (lower fuel consumption, less CO 2 ). The change in blister dimension for the product containing fluvastatin active ingredient Previous blister dimension: 88 x 138 mm New blister dimension: 56 x 146 mm • 25% reduction of blister surface • 20% reduction of folding box volume